Deerfield Private Design International II, L.P.'s Net Worth

Estimate Recalculated Sep 19, 2024 01:58AM EST

Who is Deerfield Private Design International II, L.P.

Deerfield Private Design International II, L.P. does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Dicerna Pharmaceuticals Inc, Auspex Pharmaceuticals, Inc., TriVascular Technologies, Inc., AVADEL PHARMACEUTICALS PLC, ALIMERA SCIENCES INC, and Nivalis Therapeutics, Inc..

SEC CIK

Deerfield Private Design International II, L.P.'s CIK is 0001483686

Past Insider Trading and Trends

No data available

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Dicerna Pharmaceuticals Inc

Investor

Updated Nov 25, 2014


Form 4	-15.36%	-321.96K	$11.36	-$3.66M	Nov 25, 2014	1.77M	Sale	—	Nov 21 - Nov 25
Form 4	-100.00%	-214.16K	$9.05	-$1.94M	Nov 10, 2014	2.10M	Sale	—	Nov 07
Form 4	-4.27%	-117.78K	$11.40	-$1.28M	Oct 15, 2014	2.64M	Sale	—	Oct 10 - Oct 15

Showing 3 results

Auspex Pharmaceuticals, Inc.

Investor

Updated May 07, 2015


Form 4	-100.00%	-4.45M	—	—	May 07, 2015	—	Disposition	—	May 05
Form 4	50.86%	1.50M	$56.50	$84.75M	Jan 28, 2015	4.45M	Purchase	—	Jan 28
Form 3	—	—	—	—	Dec 22, 2014	2.95M	—	—	—
Form 4	-48.93%	-3.81M	$12.00	$8.40M	Feb 11, 2014	3.98M	Buy-Options	—	Feb 10

Showing 4 results

TriVascular Technologies, Inc.

Investor

Updated Apr 22, 2014


Form 4	168.33%	1.06M	$12.01	—	Apr 22, 2014	1.70M	Purchase	—	Apr 22

Showing 1 results

AVADEL PHARMACEUTICALS PLC

Investor

Updated Jun 25, 2018

View Quote Details


Form 4	-10.69%	-114.03K	$5.99	-$683.31K	Jun 25, 2018	3.67M	Sale	—	Jun 25
Form 3	—	—	—	—	May 04, 2018	3.79M	—	—	—

Showing 2 results

ALIMERA SCIENCES INC

Investor

Updated Dec 08, 2015

View Quote Details


Form 4	5.22%	272.25K	$3.01	$819.58K	Dec 08, 2015	5.88M	Purchase	—	Dec 04 - Dec 08
Form 4	4.89%	243.25K	$3.00	$729.48K	Dec 03, 2015	5.61M	Purchase	—	Dec 01 - Dec 03
Form 4	1.49%	73.25K	$2.98	$218.48K	Nov 10, 2015	5.36M	Purchase	—	Nov 06
Form 4	0.34%	16.54K	$3.00	$49.63K	Nov 03, 2015	5.29M	Purchase	—	Oct 30
Form 4	1.23%	59.34K	$3.00	$177.76K	Oct 29, 2015	5.27M	Purchase	—	Oct 27 - Oct 28
Form 4	1.27%	60.36K	$3.00	$181.11K	Oct 26, 2015	5.21M	Purchase	—	Oct 22 - Oct 26
Form 4	8.92%	390.04K	$2.97	$1.16M	Oct 21, 2015	5.15M	Purchase	—	Oct 19 - Oct 21
Form 4	7.94%	321.79K	$2.42	$779.95K	Oct 09, 2015	4.76M	Purchase	—	Oct 07 - Oct 09
Form 3	—	—	—	—	Oct 09, 2015	4.44M	—	—	—
Form 3	—	—	—	—	Oct 09, 2015	4.44M	—	—	—

Showing 10 results

Nivalis Therapeutics, Inc.

Investor

Updated Jun 25, 2015

View Quote Details


Form 4	-59.86%	-5.57M	$14.00	—	Jun 25, 2015	3.73M	Buy-Options	—	Jun 23

Showing 1 results